68Ga-DOTATATE 在儿童 SDHx 相关嗜铬细胞瘤和副神经节瘤检测中优于 18F-FDG 和解剖影像
回顾性纳入 9 例 SDHx 突变儿童患者,比较 68Ga-DOTATATE PET/CT、18F-FDG PET/CT 与 CT/MR 对嗜铬细胞瘤和副神经节瘤的检出率。68Ga-DOTATATE 病灶检出率 93.5%,显著高于 18F-FDG 的 79.4% 和 CT/MR 的 73.8%。作者认为 68Ga-DOTATATE PET/CT 可考虑作为儿童 SDHx 相关 PPGLs 的一线影像方法。
要点
- 儿童 SDHx 相关 PPGLs 中,68Ga-DOTATATE PET/CT 病灶检出率 93.5%,高于 18F-FDG PET/CT 的 79.4%。
- 68Ga-DOTATATE PET/CT 病灶检出率也高于 CT/MR 的 73.8%,差异有统计学意义。
- 除腹部(不含肾上腺和肝脏)病灶外,68Ga-DOTATATE 各区域检出率等于或优于其他方法。
核心结论
- 作者初步研究显示,在儿童 SDHx 相关 PPGLs 定位中,68Ga-DOTATATE PET/CT 优于 18F-FDG PET/CT 和 CT/MR,但腹部(不含肾上腺和肝脏)病灶例外。
- 作者建议,68Ga-DOTATATE 可考虑作为儿童 SDHx 相关 PPGLs 的一线影像方法。
研究设计与样本
- 回顾性研究纳入 9 例 SDHx 突变儿童患者(女:男=5:4,年龄 14.6±2.0 岁;SDHB:SDHA:SDHD=7:1:1)。
- 初诊时 7/9 例已有转移性疾病;患者接受 CT/MR、68Ga-DOTATATE PET/CT(n=9)、18F-FDG PET/CT(n=8)和 18F-FDG PET/MR(n=1)。
- 以所有功能和解剖影像的综合结果为影像参照,按病灶、区域和患者计算检出率。
主要发现
- 9 例中 8 例影像学阳性,影像参照共显示 107 个病灶、分布于 22 个解剖区域。
- 病灶检出率:68Ga-DOTATATE PET/CT 93.5%(95%CI 87.0%–97.3%)vs 18F-FDG PET/CT 79.4%(95%CI 70.5%–86.6%)vs CT/MR 73.8%(95%CI 64.5%–81.9%)。
- 68Ga-DOTATATE PET/CT 病灶检出率显著高于 18F-FDG PET/CT(p=0.001)和 CT/MR(p<0.001)。
- 区域检出率:68Ga-DOTATATE PET/CT 100%(95%CI 84.6%–100%),18F-FDG PET/CT 和 CT/MR 均为 90.9%(95%CI 70.8%–98.9%)。
- 患者检出率:68Ga-DOTATATE PET/CT、18F-FDG PET/CT 和 CT/MR 均为 100%(95%CI 63.1%–100%)。
关键数值与推荐
- 病灶检出率:68Ga-DOTATATE PET/CT 93.5%(95%CI 87.0%–97.3%),18F-FDG PET/CT 79.4%(95%CI 70.5%–86.6%),CT/MR 73.8%(95%CI 64.5%–81.9%)。
- 68Ga-DOTATATE PET/CT 与 18F-FDG PET/CT 比较 p=0.001,与 CT/MR 比较 p<0.001。
- 区域检出率:68Ga-DOTATATE PET/CT 100%(95%CI 84.6%–100%),18F-FDG PET/CT 和 CT/MR 均为 90.9%(95%CI 70.8%–98.9%)。
- 患者检出率:三种方法均为 100%(95%CI 63.1%–100%)。
临床怎么用
- 作者认为,68Ga-DOTATATE 可考虑作为儿童 SDHx 相关 PPGLs 的一线影像方法。
- 作者指出,除腹部(不含肾上腺和肝脏)病灶外,68Ga-DOTATATE PET/CT 在各解剖区域的病灶检出率等于或优于 18F-FDG PET/CT 和 CT/MR。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate and compare diagnostic performance of 68Ga-DOTA(0)-Tyr(3)-octreotate (68Ga-DOTATATE) with 18F-fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) and anatomic imaging using computed tomography and/or magnetic resonance (CT/MR) imaging in detection of SDHx-related pheochromocytomas and paragangliomas (PPGLs) in pediatric patients. METHODS: Nine pediatric patients (5:4, girls:boys; 14.6 ± 2.0 years) with an SDHx-related mutation (SDHB:SDHA:SDHD, n = 7:1:1) were included in this retrospective study. At the time of initial diagnosis, 7/9 patients had metastatic disease. They underwent CT/MR imaging along with PET/CT using 68Ga-DOTATATE (n = 9), 18F-FDG (n = 8), and positron emission tomography-magnetic resonance imaging (PET/MR) using 18F-FDG (n = 1). In this manuscript, 18F-FDG PET/CT refers to both 18F-FDG PET/CT and 18F-FDG PET/MR. The per-lesion, per-region, and per-patient detection rates were compared and calculated for each of the imaging modalities. A composite of all functional and anatomic imaging studies served as the imaging comparator. RESULTS: Eight out of nine patients were positive for PPGLs on the imaging studies that demonstrated 107 lesions in 22 anatomic regions on the imaging comparator. The per-lesion detection rates for 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, and CT/MR imaging were 93.5% (95%CI, 87.0% to 97.3%); 79.4% (95%CI, 70.5% to 86.6%); and 73.8% (95%CI, 64.5% to 81.9%), respectively. The per-lesion detection rate for 68Ga-DOTATATE PET/CT was significantly higher than that of 18F-FDG PET/CT (p = 0.001) or CT/MR imaging (p < 0.001). In all of the anatomic regions except abdomen, the per-lesion detection rates for 68Ga-DOTATATE PET/CT was found to be equal or superior to 18F-FDG PET/CT, and CT/MR imaging. The per-region detection rate was 100% (95%CI, 84.6% to 100%) for 68Ga-DOTATATE PET/CT and 90.9% (95%CI, 70.8% to 98.9%) for both 18F-FDG PET/CT and CT/MR imaging. The per-patient detection rates for 68Ga-DOTATATE PET/CT, 18FDG PET/CT, and CT/MR imaging were all 100% (95%CI, 63.1% to 100%). CONCLUSION: Our preliminary study demonstrates the superiority of 68Ga-DOTATATE PET/CT in localization of SDHx-related PPGLs in pediatric population compared to 18F-FDG PET/CT and CT/MR imaging with the exception of abdominal (excluding adrenal and liver) lesions, and suggests that it might be considered as a first-line imaging modality in pediatric patients with SDHx-related PPGLs.
引用
- Jha A, Ling A, Millo C, et al. Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population. Eur J Nucl Med Mol Imaging. 2017. PMID: 29204718. doi:10.1007/s00259-017-3896-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。